Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.058%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET COMMENT: Stocks Lower As UK GDP Misses Expectations

Tue, 28th Apr 2015 09:42

LONDON (Alliance News) - UK shares are lower mid-morning Tuesday, giving up Monday's gains, as Standard Chartered reported a drop in pretax profit and the last GDP reading ahead of the UK General Election missed expectations.

The FTSE 100 is down 0.8% at 7,046.84, with only 13 stocks in the green, after reaching a new intraday high at 7,122.37 on Monday. The FTSE 250 is down 0.5% at 17,694.09, while the AIM All-Share is down 0.1% at 754.77.

European indices also are trading lower, with the CAC 40 in Paris down 0.9% and the DAX 30 in Frankfurt down 0.6%.

UK economic growth slowed more than expected in the first quarter, preliminary estimate published by the Office for National Statistics revealed Tuesday.

Gross domestic product expanded 0.3% sequentially during January to March period, the slowest growth since the fourth quarter of 2012. The growth rate was forecast to slow to 0.5% from 0.6% logged in the fourth quarter of 2014. Output of the dominant service sector gained 0.5%, while construction and production declined 1.6% and 0.1%, respectively. Agriculture output was down 0.2%.

Year-on-year, GDP advanced 2.4% in the first quarter, slower than the expected increase of 2.6%.

The pound declined to USD1.5172 following the UK GDP release, but recovered shortly after. The sterling currently trades at USD1.5228.

Standard Chartered shares are trading down 0.9% after the emerging markets bank reported a 22% drop in first quarter pretax profit, due to pressure on operating income and higher charges for bad loans.

The bank, which is focused on Asia, Africa and the Middle East, said it made a USD1.47 billion pretax profit in the quarter ended March 31, compared with USD1.88 billion in the corresponding quarter of the prior year. The income statement excludes own-credit adjustments.

Operating income fell to USD4.40 billion from USD4.57 billion, while operating expenses edged up to USD2.47 billion from USD2.45 billion. More importantly, charges for loan impairments increased to USD476 million from USD265 million.

Pharmaceutical stocks are amongst the biggest fallers Tuesday, with Shire down 2.5%, AstraZeneca down 2.1%, GlaxoSmithKline down 1.4%, Indivior down 1.3%.

However, Dechra Pharmaceuticals is up 0.6% after it said Tuesday it remains confident of meeting market expectations for its 2015 financial year following strong trading in the third quarter, though it noted sales have benefited from the phasing of pre-Easter ordering in Europe and competitor stock shortages in the US market.

BP is amongst the biggest gainers in the FTSE 100, up 1.1%, even though it said its pretax profit for the first quarter of 2015 was substantially lower than a year ago after its upstream division was hit by the lowest quarterly oil price since the start of 2009, and reduced activity, partially offset by the downstream division which experienced a lift in earnings.

The oil and gas major reported a pretax profit of USD2.27 billion in the first quarter of 2015, significantly down from USD5.27 billion a year earlier as revenue tumbled to USD54.92 billion from USD92.98 billion as its upstream division took a substantial hit, partially due to lower oil prices and reduced activity. BP said its quarterly dividend will be 10.00 cents per share.

Liberum says BP results beat consensus expectations, and it expects small positive changes to consensus to follow.

Societe Generale intitiated International Consolidated Airlines Group with a Buy recommendation and a price target of 750 pence. However, the British Airways owner is trading down 1.0% at 578.82p.

In the FTSE 250, Kier Group is amongst the biggest gainers, up 1.2%, after the property and construction services company said it has struck a deal to acquire UK-based infrastructure repair and maintenance services company Mouchel in a GBP265 million deal, to be backed by a rights issue.

Allied Minds is one of the worst performers in the mid-cap index, down 1.9%. The US-focused science and technology development and commercialisation company reported a net loss of USD45.5 million for 2014, compared with a loss of USD34.5 million a year earlier, as a rise in both R&D and selling, general and administrative expenses more than offset a rise in revenue to USD7.7 million from USD2.9 million. It also said its founder will step down as chairman and later leave the board.

Outside individual stocks, analysts say investors are already focusing on the US Federal Reserve meeting starting on Wednesday.

"Markets are becoming increasingly cautious as the key Federal Open Market Committee meeting begins to dominate the thoughts of traders. It is notable this time around though that in the past few trading sessions as we approach the meeting, the US dollar has been under a little more pressure this time around," says Hantec Markets analyst Richard Perry.

On Monday, Wall Street failed to sustain an early upward move, which had sent the S&P 500 and the Nasdaq Composite to reach new intraday highs, and closed lower.

US futures point to a lower opening Tuedsay, with the DJIA and the S&P 500 pointed down 0.2% and the Nasdaq 100 seen down 0.1%.

Still in the economic calendar, in the US, the Redbook index is due at 1355 BST and consumer confidence is at 1500 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.